INTELLIA THERAPEU DL-,01 WKN: A2AG6H ISIN: US45826J1051 Kürzel: NTLA Forum: Aktien Thema: Hauptdiskussion

Hab auch mal die Hälfte raus. Der Rest bleibt drin. Vielleicht sehen wir noch 200€ 😂

Ich bin auch mit nem Teil raus. Habe den in Crispr mit rein.

Ja, ist schon heftig. Ich hatte jetzt auch erstmal anteilig realisiert.

Wird mir langsam unheimlich. Höher bewertet als der Marktführer Crispr Therapeutics.

How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna https://www.cnbc.com/2021/06/30/how-crispr-gene-editing-will-treat-disease-intellia-founder-doudna-.html KEY POINTS • CRISPR gene editing, which slices DNA to treat diseases, had its first-ever systemic delivery in a human body. • Jennifer Doudna, who won the 2020 Nobel Prize in chemistry for her work on CRISPR, called the early success of the technology "one of the fastest rollouts I think of technology from the fundamental, initial science to an actual application." • Intellia Therapeutics, the biotech she co-founded, has seen its stock rise over 100% this month. ...

👍🍀

Omg was passiert hier??? 🚀

Unglaublich Dachte ich bin zu spät und trotzdem 50% plus 😂😂😂

Nun wurde das Offering konkretisiert: Intellia Therapeutics Announces Pricing of Public Offering of Common Stock https://www.globenewswire.com/news-release/2021/06/30/2255260/0/en/Intellia-Therapeutics-Announces-Pricing-of-Public-Offering-of-Common-Stock.html ...announced today the pricing of an underwritten public offering of 4,137,931 shares of its common stock at a public offering price of $145.00 per share. Intellia also granted the underwriters a 30-day option to purchase up to an additional 620,689 shares of its common stock. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $600 million, excluding any exercise of the underwriters' option to purchase additional shares. All of the shares in the offering are to be sold by Intellia.   ...

Also fallende Kurse bald? KE ist ja immer zumindest kurzfristig mit fallenden Kursen verbunden …?

Kapitalerhöhung wenn ich das richtig verstehe.

Intellia Therapeutics Announces Proposed Public Offering of Common Stock https://www.globenewswire.com/news-release/2021/06/28/2254252/0/en/Intellia-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html ...announced today that it has commenced an underwritten public offering of $400 million of shares of its common stock. Intellia also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering. All of the shares in the proposed offering are to be sold by Intellia.   ...

👀

HC Wainwright hat schon mal das Kursziel ordentlich angepasst: Intellia Therapeutics Price Target Raised to $171.00/Share From $111.00 by HC Wainwright & Co. https://www.benzinga.com/stock/NTLA/ratings

Was meint ihr? Steigt der Kurs mit den Amerikanern weiter, oder nehmen sie wohl erstmal Gewinne mit?

Wat is das denn?